Werewolf Therapeutics (HOWL) News
NASDAQ: HOWLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.9796+0.0696 (+7.65%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
HOWL news summary
We found 2 recent headlines mentioning Werewolf Therapeutics (HOWL): 2 in the past week and 2 in the past 30 days, most often from Nasdaq. HOWL is making an outsized move today, up 7.65% at $0.9796, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "New Strong Buy Stocks for October 9th", was published by Nasdaq on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Werewolf Therapeutics headlines
- New Strong Buy Stocks for October 9thLITE, HOWL, PERI, GSBD and GFF have been added to the Zacks Rank #1 (Strong Buy) List on October 9th, 2026.NasdaqPERI, GSBD, LITE, GFF
- HALO Expands ENHANZE Collaboration & Licensing Deal With ARGXHalozyme expands its ENHANZE pact with argenx to eight targets, opening the door to new milestones and royalties as revenue growth accelerates.NasdaqHALO, JNJ, ARGX, HOWL